Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
herpesvirus of turkeys + infectious bursal disease vaccine
- Development stage
- Unknown
- Lead developer
- Boehringer Ingelheim
- Modality
- Vaccines & Immunotherapeutics
- Administration
- In Ovo, Subcutaneous
01
Overview
This is a combined veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the poultry industry. It is designed to provide simultaneous protection against Marek's Disease and Infectious Bursal Disease (IBD), also known as Gumboro disease. The vaccine typically utilizes the Herpesvirus of Turkeys (HVT) as a backbone, which is effective against Marek's Disease and often serves as a recombinant viral vector to deliver key antigens (such as the VP2 protein) from the Infectious Bursal Disease Virus (IBDV). This dual-action approach allows for early administration, such as *in ovo* or to day-old chicks, ensuring robust and long-lasting immunity in commercial poultry flocks.
- Brand names
- MEVAC HVT+IBD
- Other names
- HVT + IBDHVT + Gumboro vaccineHerpesvirus of Turkey + Infectious Bursal Disease Vaccine
Beyond the preview
Go deeper on herpesvirus of turkeys + infectious bursal disease vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on herpesvirus of turkeys + infectious bursal disease vaccine.